Evidence map›Paper›PMID 42812966›Full record

ArticleSkin health and disease2026

Identifying and addressing obstacles to optimal alopecia areata and atopic dermatitis care in the UK.

Stephanie Gallard, Sue Schilling, Suzi Holland, Megan Mowbray, Sophia Conner, Manjit Kaur, Yousaf Aftab, Benoit Raymond, Gulraj Matharu, Karim Amer and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Skin health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Stephanie GallardDermatology GPSI for the Liverpool ICATS, Liverpool University Hospitals FT, Liverpool, UK.
Sue SchillingAlopecia UK, Shipley, UK.
Suzi HollandEczema Outreach Support, Linlithgow, UK.
Megan MowbrayDepartment of Dermatology, Queen Margaret Hospital, Dunfermline, UK.
Sophia ConnerDepartment of Dermatology, West Glasgow Ambulatory Care Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.
Manjit KaurDepartment of Dermatology, Solihull Hospital, University Hospitals Birmingham NHS Foundation Trust, Solihull, UK.
Yousaf AftabPfizer Ltd, Walton Oaks, UK.
Benoit RaymondPfizer Ltd, Walton Oaks, UK.
Gulraj MatharuPfizer Ltd, Walton Oaks, UK.
Karim AmerPfizer Ltd, Walton Oaks, UK.
Kave ShamsDermatology Department, The Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Leila AsfourDermatology Department, Chelsea and Westminster NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0002-0049-8377

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alopecia areata (AA) and atopic dermatitis (AD) are both chronic inflammatory conditions, associated with physical and significant psychosocial burden, with patients facing considerable barriers to care in the UK. In this perspective, we explore gaps in care in the UK healthcare system for patients with AA and AD, gaining insights from healthcare professionals, patients and patient advocates to identify opportunities for improvement within primary care and secondary care.

Identifiers

PMID42812966
PMCPMC13623443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.